GlassScriptPhysician profile
Neil R Johnson
NPI 1144243973
$3,051.46
in general payments reported to CMS, 2019-2025
8 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $54.36 · 2021: $263 · 2023: $1,877 · 2024: $239 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,558 · Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,558.48 |
| Food and Beverage | $814.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,534.03 | 2019-2025 | Secur-Fit, Mako, Triathlon |
| Smith+Nephew, INC. | $245.09 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Real Intelligence |
| Heron Therapeutics, INC. | $79.57 | 2021 | |
| Nalu Medical, INC. | $77.59 | 2021 | |
| Orthofix Medical, INC. | $50.35 | 2023-2025 | Physio-Stim |
| Orthalign INC | $37.31 | 2019 | |
| Convatec INC. | $27.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$192,072.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.